ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

4BB 4basebio Plc

1,035.00
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
4basebio Plc LSE:4BB London Ordinary Share GB00BMCLYF79 ORD EUR1.00
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,035.00 1,000.00 1,070.00 1,035.00 1,035.00 1,035.00 96 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 335k -5.15M -0.4180 -24.76 127.51M

4basebio UK Societas Holding(s) in Company

19/02/2021 5:35pm

UK Regulatory


 
TIDM4BB 
 
TR-1: Standard form for notification of major holdings 
 
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the 
FCA in Microsoft Word format if possible)i 
 
1a. Identity of the issuer or the underlying                4basebio UK Societas 
issuer of existing shares to which voting 
rights are attachedii: 
 
1b. Please indicate if the issuer is a non-UK issuer   (please mark with an "X" 
if appropriate) 
 
Non-UK issuer 
 
2. Reason for the notification (please mark the appropriate box or boxes with 
an "X") 
 
An acquisition or disposal of voting rights 
 
An acquisition or disposal of financial instruments 
 
An event changing the breakdown of voting rights                                          x 
 
Other (please specify)iii: 
 
3. Details of person subject to the notification obligationiv 
 
Name                                            Wilhelm K. T. Zours 
 
City and country of registered office (if       Heidelberg, Germany 
applicable) 
 
4. Full name of shareholder(s) (if different from 3.)v 
 
Name                                            DELPHI Unternehmensberatung 
                                                Aktiengesellschaft 
 
City and country of registered office (if       Heidelberg, Germany 
applicable) 
 
5. Date on which the threshold was crossed or   17/02/2021 
reachedvi: 
 
6. Date on which issuer notified (DD/MM/YYYY):  17/02/2021 
 
7. Total positions of person(s) subject to the notification obligation 
 
                      % of voting     % of voting rights  Total of both in   Total number of 
                    rights attached   through financial     % (8.A + 8.B)   voting rights of 
                   to shares (total      instruments                            issuervii 
                       of 8. A)       (total of 8.B 1 + 
                                            8.B 2) 
 
Resulting               20.27%                -                20.27%          12,317,473 
situation on the 
date on which 
threshold was 
crossed or reached 
 
Position of                -                  -                   - 
previous 
notification (if 
applicable) 
 
 
 
 
8. Notified details of the resulting situation on the date on which the 
threshold was crossed or reachedviii 
 
A: Voting rights attached to shares 
 
Class/type of              Number of voting rightsix                 % of voting rights 
shares 
ISIN code (if             Direct            Indirect              Direct             Indirect 
possible)                (Art 9 of         (Art 10 of       (Art 9 of Directive     (Art 10 of 
                      Directive 2004/  Directive 2004/109/ 2004/109/EC) (DTR5.1)  Directive 2004/ 
                     109/EC) (DTR5.1)    EC) (DTR5.2.1)                               109/EC) 
                                                                                    (DTR5.2.1) 
 
GB00BLD8ZL39                 -              2,496,933                -                20.27% 
 
SUBTOTAL 8. A                      2,496,933                               20.27% 
 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
(DTR5.3.1.1 (a)) 
 
Type of financial    Expiration Exercise/               Number of voting rights  % of voting 
instrument           datex      Conversion Periodxi     that may be acquired if  rights 
                                                        the instrument is 
                                                        exercised/converted. 
 
N/A 
 
                                SUBTOTAL 8. B 1 
 
B 2: Financial Instruments with similar economic effect according to Art. 13(1) 
(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 
Type of          Expiration     Exercise/       Physical or cash  Number of      % of voting 
financial        datex          Conversion      settlementxii     voting rights  rights 
instrument                      Period xi 
 
N/A 
 
                                                SUBTOTAL 8.B.2 
 
 
 
 
 
 
 
9. Information in relation to the person subject to the notification obligation 
(please mark the 
applicable box with an "X") 
 
Person subject to the notification obligation is not controlled by any natural 
person or legal entity and does not control any other undertaking(s) holding 
directly or indirectly an interest in the (underlying) issuerxiii 
 
Full chain of controlled undertakings through which the voting rights and/or               X 
the 
financial instruments are effectively held starting with the ultimate 
controlling natural person or legal entityxiv (please add additional rows as 
necessary) 
 
        Namexv          % of voting rights if    % of voting rights      Total of both if it 
                       it equals or is higher     through financial      equals or is higher 
                         than the notifiable      instruments if it      than the notifiable 
                              threshold          equals or is higher          threshold 
                                                 than the notifiable 
                                                      threshold 
 
Wilhelm K. T. Zours 
 
DELPHI                          5.18%                                           5.18% 
Unternehmensberatung 
Aktiengesellschaft 
 
Deutsche Balaton                4.11%                                           4.11% 
Aktiengesellschaft 
 
Sparta AG                      10.97%                                          10.97% 
 
10. In case of proxy voting, please identify: 
 
Name of the proxy holder                       N/A 
 
The number and % of voting rights held         N/A 
 
The date until which the voting rights will be N/A 
held 
 
11. Additional informationxvi 
 
Wilhelm K. T. Zours controls circa 48% of 4basebio AG, who in turn holds 30% of 
the voting rights of 4basebio UK Societas. 
 
 
 
 
Place of completion  Heidelberg, Germany 
 
Date of completion   19/02/2021 
 
 
 
END 
 
 

(END) Dow Jones Newswires

February 19, 2021 12:35 ET (17:35 GMT)

1 Year 4basebio Chart

1 Year 4basebio Chart

1 Month 4basebio Chart

1 Month 4basebio Chart

Your Recent History

Delayed Upgrade Clock